SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-12-000050
Filing Date
2012-11-01
Accepted
2012-11-01 14:53:23
Documents
14
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 937232
2 ex10_1.htm EX-10.1 54260
3 ex10-2.htm EX-10.2 49537
4 ex10-3.htm EX-10.3 69760
5 ex31-1.htm EX-31.1 7699
6 ex31-2.htm EX-31.2 7689
7 ex32-1.htm EX-32.1 2638
8 ex32-2.htm EX-32.2 2623
  Complete submission text file 0001367644-12-000050.txt   4886906

Data Files

Seq Description Document Type Size
9 ebs-20120930.xml EX-101.INS 626827
10 ebs-20120930.xsd EX-101.SCH 26076
11 ebs-20120930_cal.xml EX-101.CAL 52954
12 ebs-20120930_def.xml EX-101.DEF 111183
13 ebs-20120930_lab.xml EX-101.LAB 399316
14 ebs-20120930_pre.xml EX-101.PRE 246625
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 121173166
SIC: 2834 Pharmaceutical Preparations